The anti-blood clot regimen that adds the drug clopidogrel (Plavix) to aspirin treatment is unlikely to prevent recurrent strokes and may increase the risk of bleeding and death in patients with subcortical stroke, according to research presented at the American Stroke Association's International Stroke Conference 2012.
Because of these preliminary results, researchers ended the anti-clotting part of the Secondary Prevention of Small Subcortical Strokes Trial (SPS3) in August 2011.
The part of the study that examines the effect of high blood pressure treatments will continue.
Friday, February 10, 2012
Hospital Pharmacy Europe - Clopidogrel with aspirin 'does not prevent strokes'
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment